These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8782453)

  • 21. Immunophilins and the nervous system.
    Snyder SH; Sabatini DM
    Nat Med; 1995 Jan; 1(1):32-7. PubMed ID: 7584950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dominant mutations confer resistance to the immunosuppressant, rapamycin, in variants of a T cell lymphoma.
    Dumont FJ; Staruch MJ; Grammer T; Blenis J; Kastner CA; Rupprecht KM
    Cell Immunol; 1995 Jun; 163(1):70-9. PubMed ID: 7538911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inducible gene expression and protein translocation using nontoxic ligands identified by a mammalian three-hybrid screen.
    Liberles SD; Diver ST; Austin DJ; Schreiber SL
    Proc Natl Acad Sci U S A; 1997 Jul; 94(15):7825-30. PubMed ID: 9223271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of immunosuppressants FK506 and rapamycin on the heterooligomeric form of the progesterone receptor.
    Renoir JM; Le Bihan S; Mercier-Bodard C; Gold A; Arjomandi M; Radanyi C; Baulieu EE
    J Steroid Biochem Mol Biol; 1994 Jan; 48(1):101-10. PubMed ID: 7510997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of immunosuppressants FK506 and rapamycin on the function of progesterone receptor: protein "p59-HBI", intersection between immunology and endocrinology?].
    Renoir JM; Radanyi C; Baulieu EE
    C R Acad Sci III; 1992; 315(11):421-8. PubMed ID: 1284044
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A putative sirolimus (rapamycin) effector protein.
    Chen Y; Chen H; Rhoad AE; Warner L; Caggiano TJ; Failli A; Zhang H; Hsiao CL; Nakanishi K; Molnar-Kimber KL
    Biochem Biophys Res Commun; 1994 Aug; 203(1):1-7. PubMed ID: 7521160
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FK 506 and rapamycin: molecular probes of T-lymphocyte activation.
    Bierer BE; Jin YJ; Fruman DA; Calvo V; Burakoff SJ
    Transplant Proc; 1991 Dec; 23(6):2850-5. PubMed ID: 1721296
    [No Abstract]   [Full Text] [Related]  

  • 28. Identification of an 11-kDa FKBP12-rapamycin-binding domain within the 289-kDa FKBP12-rapamycin-associated protein and characterization of a critical serine residue.
    Chen J; Zheng XF; Brown EJ; Schreiber SL
    Proc Natl Acad Sci U S A; 1995 May; 92(11):4947-51. PubMed ID: 7539137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular basis of immunosuppressive drug action: regulation of steroid receptor-mediated transcription by FK 506.
    Butt TR; Graumann K; Aziz S
    Transplant Proc; 1996 Apr; 28(2):979-80. PubMed ID: 8623486
    [No Abstract]   [Full Text] [Related]  

  • 30. Isolation of a human cDNA encoding a 25 kDa FK-506 and rapamycin binding protein.
    Wiederrecht G; Martin MM; Sigal NH; Siekierka JJ
    Biochem Biophys Res Commun; 1992 May; 185(1):298-303. PubMed ID: 1376117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mammalian target of rapamycin: immunosuppressive drugs uncover a novel pathway of cytokine receptor signaling.
    Abraham RT
    Curr Opin Immunol; 1998 Jun; 10(3):330-6. PubMed ID: 9638370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene expression of FK 506-binding protein.
    Kar S; Carr B
    Transplant Proc; 1991 Dec; 23(6):2880-2. PubMed ID: 1721303
    [No Abstract]   [Full Text] [Related]  

  • 33. Immunophilins, ligands, and the control of signal transduction.
    Schreiber SL; Crabtree GR
    Harvey Lect; 1995-1996; 91():99-114. PubMed ID: 9127988
    [No Abstract]   [Full Text] [Related]  

  • 34. Mechanism of action of the immunosuppressant rapamycin.
    Dumont FJ; Su Q
    Life Sci; 1996; 58(5):373-95. PubMed ID: 8594303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A tacrolimus-related immunosuppressant with biochemical properties distinct from those of tacrolimus.
    Peterson LB; Cryan JG; Rosa R; Martin MM; Wilusz MB; Sinclair PJ; Wong F; Parsons JN; O'Keefe SJ; Parsons WH; Wyvratt M; Sigal NH; Williamson AR; Wiederrecht GJ
    Transplantation; 1998 Jan; 65(1):10-8. PubMed ID: 9448137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapamycin inhibits vascular smooth muscle cell migration.
    Poon M; Marx SO; Gallo R; Badimon JJ; Taubman MB; Marks AR
    J Clin Invest; 1996 Nov; 98(10):2277-83. PubMed ID: 8941644
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The 37 kDa immunophilin has uracil DNA glycosylase but not rotamase activity.
    Goodyear N; Murthy JN; Soldin SJ
    Clin Biochem; 1997 Aug; 30(6):497-9. PubMed ID: 9316745
    [No Abstract]   [Full Text] [Related]  

  • 38. Quantitative and temporal analysis of the cellular interaction of FK-506 and rapamycin in T-lymphocytes.
    Dumont FJ; Kastner C; Iacovone F; Fischer PA
    J Pharmacol Exp Ther; 1994 Jan; 268(1):32-41. PubMed ID: 7507994
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanism of TGFbeta receptor inhibition by FKBP12.
    Chen YG; Liu F; Massague J
    EMBO J; 1997 Jul; 16(13):3866-76. PubMed ID: 9233797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of normal skeletal muscle with FK506 or rapamycin results in halothane-induced muscle contracture.
    Brooksbank RL; Badenhorst ME; Isaacs H; Savage N
    Anesthesiology; 1998 Sep; 89(3):693-8. PubMed ID: 9743407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.